COMPREHENSIVE REVIEW ON STREPTOCOCCAL TOXIN SHOCK SYNDROME(STSS) AND MECHANISM OF ACTION OF CLINDAMYCIN AND IVIG
Published 2025-12-03
Keywords
- Streptococcal Toxic Shock Syndrome,
- Intensive care assistance,
- Streptococcal infection,
- Necrotizing fasciitis,
- Neonatal sepsis
- Clindamycin, IVIG,
- Group A gram-positive,
- Adverse Effects of Clindamycin and IVIG ...More
How to Cite
Copyright (c) 2025 Swami Vivekananda University Press

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Abstract
An extremely dangerous side effect of group A Streptococcus infection is streptococcal toxic shock syndrome, which has a high fatality rate. When treating these individuals, prompt identification, early intensive care assistance, and surgical management are crucial. The care of patients with streptococcal toxic shock syndrome depends on early detection and interdisciplinary management, which includes prompt determination of the infectious source or sources, surgical surgery, and appropriate and intensive support of failing organs. The identification and reporting of necrotizing fasciitis and other extremely invasive group A streptococcal infections linked to organ failure and shock. Streptococcal toxic-shock syndrome has been the term used to describe such extreme occurrences. The potentially fatal infectioncalled necrotizing fasciitis damages the fat and fasciabeneath the skin.A deadly infection known as neonatal sepsis can develop within the first 28 days of a neonate’s life or, in the case of preterm newborns, up to 4 weeks after the anticipated due date. Neonatal sepsis is linked to a few factors. These include immune system immaturity, low birth weight, and preterm.A consequence of an invasive Streptococcus pyogenes infection (IGAS), streptococcal toxic shock syndrome (STSS) is characterized by hypotension and end-organ failure, frequently accompanied by immunological symptoms like rash[6].Though perspectives differ on whether clindamycin should only be used in cases of streptococcal toxic shock syndrome (STSS), it is currently generally advised for usage in conjunction with a beta lactam antibiotic for severe iGAS infections. Intravenous immunoglobulin (IVIG) therapy has been proposed as a treatment adjunct that can reduce mortality. Our goal is to further demonstrate the clinical effectiveness of IVIG therapy provided to well-defined STSS patients in a comparative observational analysis.Group A gram-positive, beta-haemolytic bacterium is Streptococcus (GAS). From minor ailments like pharyngitis and impetigo to more serious conditions like necrotizing fasciitis and streptococcal toxic shock syndrome [STSS], it can cause a wide range of illnesses.
DOI - https://doi.org/10.65525/SVUP.9788198800473.2025.151-161